Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis
Top Cited Papers
Open Access
- 1 February 2006
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 117 (2) , 319-325
- https://doi.org/10.1016/j.jaci.2005.11.014
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six‐year follow‐up study.Clinical and Experimental Allergy, 2001
- Grass pollen immunotherapy for seasonal rhinitis and asthma: A randomized, controlled trialJournal of Allergy and Clinical Immunology, 2001
- Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paper☆☆☆★★★♢Journal of Allergy and Clinical Immunology, 1998
- Symptom control in patients with hay fever in UK general practice: how well are we doing and is there a need for allergen immunotherapy?Clinical and Experimental Allergy, 1998
- Immunotherapy with a standardized extract. VI. Specific immunotherapy prevents the onset of new sensitizations in childrenJournal of Allergy and Clinical Immunology, 1997
- Grass pollen immunotherapy: efficacy and safety during a 4‐year follow‐up studyAllergy, 1995
- A controlled dose-response study of immunotherapy with standardized, partially purified extract of house dust mite: Clinical efficacy and side effectsJournal of Allergy and Clinical Immunology, 1993
- Position Paper: ImmunotherapyAllergy, 1993
- Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs.BMJ, 1991
- Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitisClinical and Experimental Allergy, 1991